Additionally, previous studies have identified E2F1 as a critical factor in regulating tumor stem cell characteristics and signaling pathways [56], playing a central role in chemotherapy resistance and mediating autophagy induced by gemcitabine in pancreatic cancer cells [57]. Here, E2F1 is linked to pancreatic neoplasm.